12368 Federal Register / Vol. 74, No. 55 / Tuesday, March 24, 2009 / Notices 

TABLE 1.—ESTIMATED ANNUAL REPORTING BURDEN1—Continued 

21 CFR Section No. of 

Respondents 

Annual 

Frequency 

per Response 

Total Annual 

Responses 

Hours per 

Response Total Hours 

203.37(b) 50 40 2,000 .25 500 

203.37(c) 1 1 1 1 1 

203.37(d) 50 1 50 .08 4 

203.39(g) 1 1 1 1 1 

Total 2,285,535.50 

1There are no capital costs or operating and maintenance costs associated with this collection of information. 

TABLE 2.—ESTIMATED ANNUAL RECORDKEEPING BURDEN1

21 CFR Section No. of 

Recordkeepers 

Annual Frequency 

per 

Recordkeeping 

Total Annual 

Records 

Hours per 

Record Total Hours 

203.23(a) and (b) 31,676 5 158,380 .25 39,595 

203.23(c) 31,676 5 158,380 .08 12,670 

203.30(a)(2) and 203.31(a)(2) 2,208 100 220,800 .50 110,400 

203.31(d)(1) and (d)(2) 2,208 1 2,208 40 88,320 

203.31(d)(4) 442 1 442 24 10,608 

203.31(e) 2,208 1 2,208 1 2,208 

203.34 90 1 90 40 3,600 

203.37(a) 50 4 200 6 1,200 

203.37(b) 50 40 2,000 6 12,000 

203.39(d) 65 1 65 1 65 

203.39(e) 3,221 1 3,221 .50 1,610 

203.39(f) 3,221 1 3,221 8 25,768 

203.39(g) 3,221 1 3,221 8 25,768 

203.50(a) 0 0 0 0 0 

203.50(b) 0 0 0 0 0 

203.50(d) 0 0 0 0 0 

Total 324,092 

1There are no capital costs or operating and maintenance costs associated with this collection of information. 

Dated: March 17, 2009. 

Jeffrey Shuren, 

Associate Commissioner for Policy and 

Planning. 

[FR Doc. E9–6394 Filed 3–23–09; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel. Vaccine Design PO1. 

Date: April 16, 2009. 

mstockstill on PROD1PC66 with NOTICES

Federal Register / Vol. 74, No. 55 / Tuesday, March 24, 2009 / Notices 12369 

Time: 10 a.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6700B 

Rockledge Drive, Bethesda, MD 20817. 

Contact Person: Kenneth E. Santora, PhD., 

Scientific Review Officer, Scientific Review 

Program, NIH/NIAID/DHHS, Room 3146, 

6700B Rockledge Drive, MSC 7616, Bethesda, 

MD 20892, 301–451–2605. ks216i@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: March 18, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–6469 Filed 3–23–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

Heart Pumps for Children with 

Cardiomyopathy. 

Date: April 14, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: Hilton Crystal City Reagan National 

Airport, 2399 Jefferson Davis Highway, 

Arlington, VA 22202. 

Contact Person: Robert Blaine Moore, PhD, 

Scientific Review Officer, Review Branch/ 

DERA, National Heart, Lung, and Blood 

Institute, 6701 Rockledge Drive, Room 7213, 

Bethesda, MD 20892, 301–594–8394, 

mooreb@nhlbi.nih.gov. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

Characterizing the Blood Stem Cell Niche. 

Date: April 23, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott, 5151 Pooks Hill 

Road, Bethesda, MD 20814. 

Contact Person: Robert T. Su, PhD, 

Scientific Review Officer, Review Branch/ 

DERA, National Heart, Lung, and Blood 

Institute, 6701 Rockledge Drive, Room 7202, 

Bethesda, MD 20892–7924, 301–435–0297, 

sur@mail.nih.gov. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

Loan Repayment Program (L30’s). 

Date: April 30, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call) 

Contact Person: Rina Das, PhD, Scientific 

Review Officer, Review Branch/DERA, 

National Heart, Lung, and Blood Institute, 

6701 Rockledge Drive, Room 7200, Bethesda, 

MD 20892–7924, 301–435–0297, 

dasr2@nhlbi.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS) 

Dated: March 18, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–6476 Filed 3–23–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of General Medical 

Sciences; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

General Medical Sciences Special Emphasis 

Panel. 2009 New Innovator Award PreApplication Review. 

Date: April 22, 2009. 

Time: 7 a.m. to 11:59 p.m. 

Agenda: To review and evaluate review of 

2009 New Innovator pre-applications. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, Bethesda, 

MD 20892, (Virtual Meeting). 

Contact Person: Richard T. Okita, PhD, 

Program Director, Pharmacological and 

Physiological Sciences Branch, National 

Institute of General Medical Sciences, 

National Institutes of Health, Natcher 

Building, Room 2AS–49, Bethesda, MD 

20892, 301–594–4469. okitar@nigms.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.375, Minority Biomedical 

Research Support; 93.821, Cell Biology and 

Biophysics Research; 93.859, Pharmacology, 

Physiology, and Biological Chemistry 

Research; 93.862, Genetics and 

Developmental Biology Research; 93.88, 

Minority Access to Research Careers; 93.96, 

Special Minority Initiatives, National 

Institutes of Health, HHS) 

Dated: March 18, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–6470 Filed 3–23–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel. Bioinformatics Resource 

Centers for Infectious Diseases. 

Date: April 22, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: Residence Inn Bethesda, 7335 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: Lynn Rust, PhD, Scientific 

Review Officer, Scientific Review Program, 

Division of Extramural Activities, National 

Institutes of Health/NIAID, 6700B Rockledge 

mstockstill on PROD1PC66 with NOTICES